Handl Therapeutics

Handl Therapeutics is a biotechnology company based in Leuven, Belgium, founded in 2019. It focuses on developing in vivo gene therapy aimed at addressing complex neurodegenerative diseases. The company has established a therapeutics platform designed to deliver advanced medicines to the market, targeting significant unmet medical needs in healthcare. Through its innovative approach, Handl Therapeutics seeks to transform the treatment landscape for patients suffering from these challenging conditions.